Alexion Pharmaceuticals (NASDAQ:ALXN): Q4 Non-GAAP EPS of $2.71 beats by $0.10; GAAP EPS of $4.00 beats by $1.91.
Revenue of $1.38B (+22.1% Y/Y) beats by $60M.
https://seekingalpha.com/news/3536184-alexion-pharmaceuticals-eps-beats-0_10-beats-on-revenue
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.